EXO Biologics
Develops biopharmaceuticals using extracellular vesicles for therapeutic purposes.
Launch date
Employees
Market cap
-
Enterprise valuation
€36—54m (Dealroom.co estimates Apr 2024.)
Liège Liège (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
* | €9.0m | Series A | |
* | N/A | €7.0m | Grant |
| Total Funding | €16.0m | ||